Fortfahren mit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Über diesen Artikel
Assay:
>95% (SDS-PAGE)
Recombinant:
expressed in NSO cells
recombinant
expressed in NSO cells
Quality Segment
assay
>95% (SDS-PAGE)
form
buffered aqueous solution
enzyme activity
≥400 pmol/min-μg
mol wt
apparent mol wt 52-55 kDa
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... MMP1(4312)
Biochem/physiol Actions
MMP-1 initiates the breakdown of interstitial collagens.
Physical form
Supplied as a 0.2 μm filtered solution of 25 mM MES, 10 mM calcium chloride, 150 mM sodium chloride, 0.05% Brij® L23, pH 5.5.
Analysis Note
The biological activity is measured by its ability to cleave a fluorogenic peptide substrate.
Other Notes
Activity Assay Protocol
Materials:
Assay:
1. Dilute rhMMP-1 to 50 μg/mL in Assay Buffer.
2. Activate 50 μg/mL rhMMP-1 by adding APMA to a final concentration of 1 mM.
3. Incubate at 37 °C for 2 hours.
4. Dilute activated rhMMP-1 to 1 ng/μL in Assay Buffer.
5. Dilute Substrate to 20 μM in Assay Buffer.
6. Load into a black well plate 50 μL of 1 ng/μL rhMMP-1 and start the reaction by adding 50 μL of 20 μM Substrate. Include a Substrate Blank containing 50 μL Assay Buffer, 50 μL Substrate, and no rhMMP-1.
7. Read at excitiation and emission wavelengths of 320 nm and 405 nm, respectively, in kinetic mode for 5 minutes.
8. Calculate specific activity:
Specific Activity (pmol/min/μg) =Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) / amount of enzyme (μg)
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH.
Final Assay Conditions:
Per Well:
rhMMP-1: 0.050 μg
Substrate: 10 μM
Materials:
- Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% Brij-35, pH 7.5 (TCNB)
- Recombinant Human MMP-1 (rhMMP-1) (Cat. No. M9195)
- p-aminophenylmercuric acetate (APMA), (Cat. No. A9563), 100 mM stock in DMSO
- Substrate: MCA-Lys-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2
- F16 Black Maxisorp Plate
- Fluorescent Plate Reader or equivalent
Assay:
1. Dilute rhMMP-1 to 50 μg/mL in Assay Buffer.
2. Activate 50 μg/mL rhMMP-1 by adding APMA to a final concentration of 1 mM.
3. Incubate at 37 °C for 2 hours.
4. Dilute activated rhMMP-1 to 1 ng/μL in Assay Buffer.
5. Dilute Substrate to 20 μM in Assay Buffer.
6. Load into a black well plate 50 μL of 1 ng/μL rhMMP-1 and start the reaction by adding 50 μL of 20 μM Substrate. Include a Substrate Blank containing 50 μL Assay Buffer, 50 μL Substrate, and no rhMMP-1.
7. Read at excitiation and emission wavelengths of 320 nm and 405 nm, respectively, in kinetic mode for 5 minutes.
8. Calculate specific activity:
Specific Activity (pmol/min/μg) =Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) / amount of enzyme (μg)
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH.
Final Assay Conditions:
Per Well:
rhMMP-1: 0.050 μg
Substrate: 10 μM
Legal Information
Brij is a registered trademark of Croda International PLC
Lagerklasse
10 - Combustible liquids
Was ist los?
WGK 2
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
PSA (Persönliche Schutzausrüstung)
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Zulassungslistungen
Zulassungslistungen werden hauptsächlich für chemische Produkte erstellt. Für nicht-chemische Produkte können hier nur begrenzte Angaben gemacht werden. Kein Eintrag bedeutet, dass keine der Komponenten gelistet ist. Es liegt in der Verantwortung des Benutzers, die sichere und legale Verwendung des Produkts zu gewährleisten.
10043-52-4
CAS No.
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.